Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (1566)	7/11/2002 9:52:28 PM
From: mopgcw	Read Replies (1) \| Respond to of 1728

Affymetrix Signs GeneChip EasyAccess Pact With Immunex DOW JONES NEWSWIRES SANTA CLARA, Calif. -- Affymetrix Inc. (AFFX) agreed to allow Immunex Corp. (IMNX) broad access to its standard and custom GeneChip arrays, instrumentation and software. An Affymetrix spokesperson wasn't immediately available to provide further details. In a press release Wednesday, Affymetrix said the EasyAccess Silver agreement will help Immunex monitor gene expression for use in biopharmaceutical research and development activities. Affymetrix' GeneChip technology is used by researchers to acquire, interpret and manage complex genetic information from applications including sequence analysis, genotyping and gene expression monitoring. Shares of Affymetrix closed Wednesday at $15.37, down $1.63, or 9.6%, on Nasdaq volume of 2.3 million shares. Average daily volume is 1.4 million shares.